We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHD icon
1076
BlackRock MuniHoldings Fund
MHD
$598M
$452K 0.01%
26,923
-1,096
-4% -$18.1K
QDEL icon
1077
QuidelOrtho
QDEL
$1.14B
$451K 0.01%
3,520
-2,158
-38% -$254K
RGEN icon
1078
Repligen
RGEN
$7.96B
$451K 0.01%
2,258
-3,457
-60% -$671K
OTRK
1079
DELISTED
Ontrak
OTRK
$450K 0.01%
154
+9
+6% +$26K
FLG
1080
Flagstar Bank National Association
FLG
$5.93B
$450K 0.01%
13,627
-357
-3% -$12.8K
RBLX icon
1081
Roblox
RBLX
$25.5B
$449K 0.01%
+4,988
New +$401K
MMP
1082
DELISTED
Magellan Midstream Partners, L.P.
MMP
$446K 0.01%
9,105
-1
-0% -$48
FXN icon
1083
First Trust Energy AlphaDEX Fund
FXN
$388M
$445K 0.01%
39,030
-2,888
-7% -$30.7K
APPH
1084
DELISTED
AppHarvest, Inc. Common Stock
APPH
$445K 0.01%
27,814
+17,514
+170% +$279K
FIZZ icon
1085
National Beverage
FIZZ
$2.96B
$444K 0.01%
+9,400
New +$456K
INGR icon
1086
Ingredion
INGR
$6.27B
$441K 0.01%
4,880
XLG icon
1087
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
$441K 0.01%
13,550
+210
+2% +$6.58K
CORT icon
1088
Corcept Therapeutics
CORT
$12.4B
$440K 0.01%
+20,000
New +$445K
OEC icon
1089
Orion
OEC
$381M
$438K 0.01%
23,050
+1,250
+6% +$24.7K
FIXD icon
1090
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
$437K 0.01%
8,161
-3,124
-28% -$167K
CSGP icon
1091
CoStar Group
CSGP
$11.7B
$435K 0.01%
5,250
+640
+14% +$55.3K
SJNK icon
1092
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$433K 0.01%
15,710
+1,197
+8% +$32.8K
CHI
1093
Calamos Convertible Opportunities and Income Fund
CHI
$1.01B
$432K 0.01%
28,462
+1,103
+4% +$16.5K
MOTI icon
1094
VanEck Morningstar International Moat ETF
MOTI
$74.2M
$431K 0.01%
12,000
OGE icon
1095
OGE Energy
OGE
$9.78B
$431K 0.01%
12,808
-52
-0.4% -$1.75K
TCRT icon
1096
Alaunos Therapeutics
TCRT
$4.59M
$431K 0.01%
1,089
+530
+95% +$247K
BETZ icon
1097
Roundhill Sports Betting & iGaming ETF
BETZ
$49.7M
$430K 0.01%
+14,153
New +$443K
VT icon
1098
Vanguard Total World Stock ETF
VT
$77.1B
$430K 0.01%
4,158
-9
-0.2% -$918
TPTX
1099
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$430K 0.01%
+5,510
New +$407K
CRSR icon
1100
Corsair Gaming
CRSR
$1.13B
$429K 0.01%
+12,882
New +$424K

Similar funds

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.